Product NDC: | 0006-0462 |
Proprietary Name: | EMEND |
Non Proprietary Name: | aprepitant |
Active Ingredient(s): | 125 mg/1 & nbsp; aprepitant |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0006-0462 |
Labeler Name: | Merck Sharp & Dohme Corp. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA021549 |
Marketing Category: | NDA |
Start Marketing Date: | 20030326 |
Package NDC: | 0006-0462-06 |
Package Description: | 1 BLISTER PACK in 1 CARTON (0006-0462-06) > 6 CAPSULE in 1 BLISTER PACK (0006-0462-01) |
NDC Code | 0006-0462-06 |
Proprietary Name | EMEND |
Package Description | 1 BLISTER PACK in 1 CARTON (0006-0462-06) > 6 CAPSULE in 1 BLISTER PACK (0006-0462-01) |
Product NDC | 0006-0462 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | aprepitant |
Dosage Form Name | CAPSULE |
Route Name | ORAL |
Start Marketing Date | 20030326 |
Marketing Category Name | NDA |
Labeler Name | Merck Sharp & Dohme Corp. |
Substance Name | APREPITANT |
Strength Number | 125 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Neurokinin 1 Antagonists [MoA],Substance P/Neurokinin-1 Receptor Antagonist [EPC] |